ATMP

ISPOR is hosting its next installment in its Signal Series on September 27th. In the talk, speakers will talk about economic evaluation of advanced therapy medicinal products (AMTPs). AMTPs include cell and gene therapies and often have a steep entry cost and uncertain long-term effects, which makes valuation difficult.